433
Federal Aviation Administration, DOT
§ 135.93
carry or operate a portable oxygen con-
centrator for personal use on board an
aircraft and a certificate holder may
allow a passenger to carry or operate a
portable oxygen concentrator on board
an aircraft operated under this part
during all phases of flight if the port-
able oxygen concentrator satisfies all
of the requirements of this paragraph
(f):
(i) Is legally marketed in the United
States in accordance with Food and
Drug Administration requirements in
title 21 of the CFR;
(ii) Does not radiate radio frequency
emissions that interfere with aircraft
systems;
(iii) Generates a maximum oxygen
pressure of less than 200 kPa gauge
(29.0 psig/43.8 psia) at 20
°
C (68
°
F);
(iv) Does not contain any hazardous
materials subject to the Hazardous Ma-
terials Regulations (49 CFR parts 171
through 180) except as provided in 49
CFR 175.10 for batteries used to power
portable electronic devices and that do
not require aircraft operator approval;
and
(v) Bears a label on the exterior of
the device applied in a manner that en-
sures the label will remain affixed for
the life of the device and containing
the following certification statement
in red lettering: ‘‘The manufacturer of
this POC has determined this device
conforms to all applicable FAA accept-
ance criteria for POC carriage and use
on board aircraft.’’ The label require-
ments in this paragraph (f)(1)(v) do not
apply to the following portable oxygen
concentrators approved by the FAA for
use on board aircraft prior to May 24,
2016:
(A) AirSep Focus;
(B) AirSep FreeStyle;
(C) AirSep FreeStyle 5;
(D) AirSep LifeStyle;
(E) Delphi RS–00400;
(F) DeVilbiss Healthcare iGo;
(G) Inogen One;
(H) Inogen One G2;
(I) Inogen One G3;
(J) Inova Labs LifeChoice;
(K) Inova Labs LifeChoice Activox;
(L) International Biophysics
LifeChoice;
(M) Invacare Solo2;
(N) Invacare XPO2;
(O) Oxlife Independence Oxygen Con-
centrator;
(P) Oxus RS–00400;
(Q) Precision Medical EasyPulse;
(R) Respironics EverGo;
(S) Respironics SimplyGo;
(T) SeQual Eclipse;
(U) SeQual eQuinox Oxygen System
(model 4000);
(V) SeQual Oxywell Oxygen System
(model 4000);
(W) SeQual SAROS; and
(X) VBox Trooper Oxygen Concen-
trator.
(2)
Operating requirements.
Portable
oxygen concentrators that satisfy the
acceptance criteria identified in para-
graph (f)(1) of this section may be car-
ried on or operated by a passenger on
board an aircraft provided the aircraft
operator ensures that all of the condi-
tions in this paragraph (f)(2) are satis-
fied:
(i)
Exit seats.
No person operating a
portable oxygen concentrator is per-
mitted to occupy an exit seat.
(ii)
Stowage of device.
During move-
ment on the surface, takeoff and land-
ing, the device must be stowed under
the seat in front of the user, or in an-
other approved stowage location so
that it does not block the aisle way or
the entryway to the row. If the device
is to be operated by the user, it must
be operated only at a seat location that
does not restrict any passenger’s access
to, or use of, any required emergency
or regular exit, or the aisle(s) in the
passenger compartment.
[Doc. No. 16097, 43 FR 46783, Oct. 10, 1978, as
amended by Amdt. 135–60, 61 FR 2616, Jan. 26,
1996; Docket FAA–2014–0554, Amdt. 135–133, 81
FR 33119, May 24, 2016; Docket FAA–2018–0119,
Amdt. 135–139, 83 FR 9175, Mar. 5, 2018]
§ 135.93 Minimum altitudes for use of
autopilot.
(a)
Definitions.
For purpose of this
section—
(1) Altitudes for takeoff/initial climb
and go-around/missed approach are de-
fined as above the airport elevation.
(2) Altitudes for enroute operations
are defined as above terrain elevation.
(3) Altitudes for approach are defined
as above the touchdown zone elevation
(TDZE), unless the altitude is specifi-
cally in reference to DA (H) or MDA, in
